SOPHARMA AD (26/2017) Additional issues on the agenda of the Annual General Meeting of Shareholders of Sopharma AD
Report no 26/2017
- 05.05.2017, 14:33
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (25/2017) Sales revenues for the first four months of 2017
Report no 25/2017- 03.05.2017, 15:08
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (24/2017) Notification for a technical mistake concerning the second date for the AGM
Report no 24/2017- 02.05.2017, 15:57
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (23/2017) Invitation for Annual General Meeting of the Shareholders of Sopharma AD
Report no 23/2017- 28.04.2017, 22:34
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (22/2017) Audited Consolidated Financial Statements of Sopharma for 2016
Report no 22/2017- 28.04.2017, 22:23
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (21/2017) INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 March 2017
Report no 21/2017- 28.04.2017, 16:05
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (19/2017) Notification - Approval for transformation
Report no 19/2017- 26.04.2017, 15:09
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (17/2017) Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00
Report no 17/2017- 20.04.2017, 17:26
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (16/2017) Sopharma AD acquired 51% of RAP Pharma International
Report no 16/2017- 18.04.2017, 18:19
- Kategoria: Biznes i finanse
- Źródło: ESPI
